拱东医疗
(605369)
| 流通市值：36.55亿 | | | 总市值：36.55亿 |
| 流通股本：2.20亿 | | | 总股本：2.20亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 588,022,932.18 | 288,585,340.3 | 1,135,701,442.27 | 845,084,320.3 |
| 营业收入 | 588,022,932.18 | 288,585,340.3 | 1,135,701,442.27 | 845,084,320.3 |
| 二、营业总成本 | 522,198,551.19 | 249,380,131.57 | 1,023,246,062.16 | 752,127,483.02 |
| 营业成本 | 408,638,817.56 | 194,922,498.09 | 819,182,797.9 | 590,427,890.11 |
| 税金及附加 | 5,648,721.39 | 3,065,384.15 | 12,576,433.76 | 8,935,216.86 |
| 销售费用 | 27,449,911.63 | 9,236,680.59 | 55,985,805.5 | 41,717,887.17 |
| 管理费用 | 44,896,555.19 | 24,990,847.54 | 92,924,788.39 | 76,162,010.4 |
| 研发费用 | 25,002,659.68 | 11,658,672.54 | 45,600,760.16 | 38,044,278.04 |
| 财务费用 | 10,561,885.74 | 5,506,048.66 | -3,024,523.55 | -3,159,799.56 |
| 其中:利息费用 | 3,160,727.88 | 1,643,893.34 | 5,650,950.56 | 5,507,067.04 |
| 其中:利息收入 | 8,648,460.47 | 4,269,830.04 | 17,841,341.08 | 13,590,208.15 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -698,475.07 | 679,294.41 | 2,314,941.97 | -557,249.18 |
| 加:投资收益 | 248,222 | -160,595.94 | -12,473,617.44 | -8,057,665 |
| 资产处置收益 | -122,769.38 | -65,150.31 | -36,738.8 | 181,313.34 |
| 资产减值损失(新) | -3,786,934.85 | -2,924,842.33 | -37,367,364.97 | -4,941,180.92 |
| 信用减值损失(新) | -2,091,128.5 | -722,192.28 | -3,424,592.13 | -3,350,567.51 |
| 其他收益 | 1,846,677.29 | 1,005,724.04 | 3,763,816.96 | 3,110,658.77 |
| 四、营业利润 | 61,219,972.48 | 37,017,446.32 | 65,231,825.7 | 79,342,146.78 |
| 加:营业外收入 | 1.42 | 0.04 | 3,352.74 | 9,177.67 |
| 减:营业外支出 | 325,217.57 | 1,799.12 | 2,400,433.49 | 256,035.79 |
| 五、利润总额 | 60,894,756.33 | 37,015,647.24 | 62,834,744.95 | 79,095,288.66 |
| 减:所得税费用 | 6,329,207.96 | 5,068,573.34 | 11,455,190.18 | 7,204,990.44 |
| 六、净利润 | 54,565,548.37 | 31,947,073.9 | 51,379,554.77 | 71,890,298.22 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 54,565,548.37 | 31,947,073.9 | 51,379,554.77 | 71,890,298.22 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 54,692,277.81 | 31,992,144.45 | 51,507,174.7 | 71,964,592.87 |
| 少数股东损益 | -126,729.44 | -45,070.55 | -127,619.93 | -74,294.65 |
| 扣除非经常损益后的净利润 | 53,073,768.72 | 31,417,044.78 | 62,223,549.18 | 80,126,777.39 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.25 | 0.15 | 0.23 | 0.33 |
| (二)稀释每股收益 | 0.25 | 0.15 | 0.23 | 0.33 |
| 八、其他综合收益 | -11,885,069.66 | -3,600,274.63 | -9,653,798.4 | -5,079,463.63 |
| 归属于母公司股东的其他综合收益 | -11,885,069.66 | -3,600,274.63 | -9,653,798.4 | -5,079,463.63 |
| 九、综合收益总额 | 42,680,478.71 | 28,346,799.27 | 41,725,756.37 | 66,810,834.59 |
| 归属于母公司股东的综合收益总额 | 42,807,208.15 | 28,391,869.82 | 41,853,376.3 | 66,885,129.24 |
| 归属于少数股东的综合收益总额 | -126,729.44 | -45,070.55 | -127,619.93 | -74,294.65 |
| 公告日期 | 2026-08-25 | 2026-04-24 | 2026-04-24 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |